Danaher Corporation (DHR) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Symbol and logo of brand danaher.com (DHR)

The EV/EBITDA dynamics of Danaher Corp. reflect the impact of Rainer Blair's strategy to optimize assets in favor of high-margin sectors. Despite a temporary stagnation in biotech equipment following the pandemic, the products remain critical. The current value is 23.35. Operational resilience is ensured by the implementation of the Danaher Business System, which effectively streamlines supply chains and consumables.

DHR Danaher Corporation Inc.: Total Company Value to Operating Income Before Depreciation Ratio in the range 11/23/2025 - 11/13/2026

Comprehensive metric breakdowns and analytics for danaher.com (DHR)

- current price and projected stock value:
Stock Price Danaher Corp|DHR - Analyst Median Target
- market capitalization details:
Market Value Danaher Corporation Inc.|DHR - Business Value
- book value of equity indicators:
Net Assets per Single Share Danaher|DHR - Book Valuation of Business|Market Cap to Net Assets Ratio danaher.com|DHR - Aggregate Business Assets
- company total debt and liquidity indicators:
Debt to Equity Danaher Corp.|DHR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Danaher|DHR - Company Aggregate Debts|Debt to Book Capitalization Ratio Danaher Corporation Inc.|DHR - Company Long-Term Liabilities|Company Short-Term Debts Danaher|Quick Liquidity danaher.com
- business earnings and investment ratios data:
DHR - Company Profit|Future Profit Danaher Corp.|DHR - Market Price to Net Income Ratio|Future Price to Earnings Danaher Corp.|DHR - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Danaher Corporation Inc.|DHR - Operating profit before amortization|Net earnings per share (EPS TTM) Danaher|DHR - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months danaher.com|DHR - Earnings per share growth this year|Earnings growth forecast for next year Danaher Corp.
- sales volume and revenue indicators:
DHR - Revenue and Sales Volume|Projected Sales Volume Danaher Corp|DHR - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Danaher Corporation Inc.
Fundamental company analysis:DHR (Danaher Corp)
Original product of Danaher Corporation

For Danaher Corp. (DHR), the link between operational efficiency and market value is determined by enterprise value and EBITDA. By analyzing the EV/EBITDA multiple, including depreciation and debt, investors assess the real value of the business, stripped of its financing structure. This chart reflects market expectations regarding the recovery in demand for bioprocessors and the synergies from the Abcam acquisition. The efficiency of the DBS system directly impacts the attractiveness of this multiple.

Competitors of Danaher Corp. (DHR)

EV/EBITDA Multiple ISRG (Intuitive Surgical Inc)|Total Company Value to Operating Income Before Depreciation Ratio Becton Dickinson & Company (BDX)|STE - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|WST (westpharma.com) - Enterprise Value to Operating Income Before Depreciation|Baxter (BAX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MASI - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio STVN|TFX (Teleflex Corp) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Merit Medical Systems (MMSI)|NVST (envistaco.com) - Business Value to Operating Income Before Depreciation|ICU Medical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Dentsply Sirona Inc XRAY|LMAT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AtriCure Medical (ATRC) - Enterprise Value to EBITDA Ratio|STAA: EV/EBITDA Multiple|Company Value to EBITDA ChromaDex (NAGE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ZimVie|Enterprise Value to Operating Income Before Depreciation ANGO (AngioDynamics Inc)|Enterprise Value to EBITDA Ratio CERS (Cerus Corp)|Enterprise Value to Operating Income Before Depreciation Ratio TKNO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Monogram Technologies MGRM|Total Company Value to Operating Income Before Depreciation Ratio Sharps Technology Inc (STSS)|InfuSystem Inc - EV/EBITDA Multiple|UTMD (Utah Medical Products Inc.) - Enterprise Value to Operating Income Before Depreciation|KRMD: EV/EBITDA Multiple|Nyxoah S.A (NYXH) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Microbot Medical Inc.|Enterprise Value to Operating Income Before Depreciation PDEX (pro-dex.com)|EV/EBITDA Multiple ZTEK|EV/EBITDA Multiple Elutia Inc (ELUT)|EV/EBITDA Multiple MLSS (Milestone Scientific Corp)|Business Value to Operating Income Before Depreciation NXGL|Retractable Tech - EV/EBITDA Multiple|Company Value to EBITDA Harvard Bioscience Inc.|Femasys (FEMY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Meihua Medical Technologies Co., Ltd. - Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio POAI|CJMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ATRI|Enterprise Value to EBITDA Ratio neurometrix.com NURO